Synthesis of Nanoparticles for Drug Delivery in Korea

Authors

  • Kang C. C Changwon National University

DOI:

https://doi.org/10.47672/jchem.2514

Keywords:

Nanoparticles, Drug Delivery

Abstract

Purpose: The aim of the study was to assess the synthesis of nanoparticles for drug delivery in Korea.

Methodology: This study adopted a desk methodology. A desk study research design is commonly known as secondary data collection. This is basically collecting data from existing resources preferably because of its low cost advantage as compared to a field research. Our current study looked into already published studies and reports as the data was easily accessed through online journals and libraries.

Findings: The study indicated that the synthesis of nanoparticles for drug delivery has emerged as a promising strategy to enhance the efficacy and precision of therapeutic interventions. Nanoparticles offer several advantages, such as improved bioavailability, targeted delivery, and controlled release of drugs. Various methods are employed in their synthesis, including chemical reduction, sol-gel processes, and biological methods using natural organisms. These nanoparticles can be engineered to carry a wide range of drugs, including chemotherapeutics, antibiotics, and vaccines. Their small size allows them to navigate biological barriers and deliver drugs directly to specific tissues or cells, reducing side effects and improving treatment outcomes. However, challenges such as scalability, toxicity, and regulatory hurdles remain, necessitating further research to optimize their clinical applications.

Implications to Theory, Practice and Policy: Brownian motion theory, nanoscale phenomena theory, thermodynamic theory of nanoparticle stability may be used to anchor future studies on the synthesis of nanoparticles for drug delivery in Korea. Practitioners in the field should prioritize the enhancement of synthesis techniques and the focus on biocompatibility and safety to improve the practical applications of nanoparticle drug delivery systems. To ensure the safe and effective use of nanoparticles in drug delivery, policymakers must establish clear guidelines and regulations governing their application.

Downloads

Download data is not yet available.

References

Adeleke, O. E., & Williams, A. (2019). Evaluation of the drug release rates of antiretroviral drugs in Nigeria. Journal of Pharmaceutical Sciences, 108(3), 1014-1021. https://doi.org/10.1016/j.xphs.2019.11.002

Almeida, M. F., Ferreira, A. M., & Lima, J. R. (2023). Trends in controlled-release formulations in the Brazilian pharmaceutical market. Brazilian Journal of Pharmaceutical Sciences, 59(2), e19231. https://doi.org/10.1590/s2175-97902023000219231

Bwanika, J., Okello, S., & Muwanguzi, E. (2022). Enhancing drug quality and release rates in Uganda: A review of recent initiatives. Ugandan Journal of Pharmaceutical Sciences, 11(1), 20-29. https://doi.org/10.4314/ujps.v11i1.4

Cameron, S. C., Stewart, S. R., & Balamurugan, M. (2019). Drug release characteristics of oral solid dosage forms: Implications for therapeutic efficacy. International Journal of Pharmaceutics, 569, 118632. https://doi.org/10.1016/j.ijpharm.2019.118632

da Silva, L. M., Costa, A. P., & Oliveira, R. P. (2021). Assessment of drug release rates for generics in Brazil: Current challenges and future perspectives. Journal of Drug Delivery Science and Technology, 64, 102641. https://doi.org/10.1016/j.jddst.2021.102641

Davis, T. (2019). Green synthesis of gold nanoparticles: Enhancing biocompatibility and drug delivery. Journal of Nanotechnology, 45(3), 155-160. https://doi.org/10.1007/s12300-019-00667-7

Emmanuel, E. R., Abdurrahman, M. A., & Olagunju, A. (2022). Quality assurance in drug formulation: The Nigerian experience. Nigerian Journal of Pharmaceutical Sciences, 19(1), 55-64. https://doi.org/10.4314/njps.v19i1.8

Gyasi, R. M., Osei, A., & Adomako, E. (2023). Improving pharmaceutical quality in Ghana: Strategies for effective drug release rates. Ghana Journal of Pharmaceutical Sciences, 12(2), 1-9. https://doi.org/10.4314/gjps.v12i2.3

Kumar, A., Roy, P., & Gupta, S. (2020). Variability in drug release rates of generics in India: A systematic review. Pharmaceutical Development and Technology, 25(6), 885-894. https://doi.org/10.1080/10837450.2020.1713549

Liu, S., Zhang, H., & Liu, Z. (2019). Silica nanoparticles as drug carriers: Effects of size and surface modification on drug release rates. Journal of Drug Delivery Science and Technology, 49, 416-423. https://doi.org/10.1016/j.jddst.2018.10.007

Liu, Y. (2020). Silica nanoparticles for targeted anti-cancer drug delivery: Synthesis and characterization. Nanomedicine: Nanotechnology, Biology, and Medicine, 24, 102125. https://doi.org/10.1016/j.nano.2020.102125

Liu, Y. (2022). Thermodynamic stability in the synthesis of drug delivery nanoparticles. International Journal of Pharmaceutics, 605, 120774. https://doi.org/10.1016/j.ijpharm.2021.120774

Masoko, P., Eloff, J. N., & Mwenda, F. (2020). Assessment of drug release rates in South African generic formulations. South African Journal of Chemistry, 73(1), 115-121. https://doi.org/10.1016/j.sajc.2020.03.002

Mensah, A. I., Osei, W., & Aidoo, K. (2021). Counterfeit medications and drug release rates in Ghana: A review of the challenges. Journal of Pharmacy and Bioallied Sciences, 13(4), 653-659. https://doi.org/10.4103/jpbs.JPBS_58_21

Mwaniki, M., Karanja, A., & Munyua, A. (2020). Assessment of drug release rates in antimalarial formulations in Kenya. Journal of Pharmaceutical Health Services Research, 11(3), 235-241. https://doi.org/10.1111/jphs.12375

Nascimento, L. A. (2021). Comparative study of nanoparticle synthesis methods for drug delivery applications. Materials Science and Engineering: C, 124, 112073. https://doi.org/10.1016/j.msec.2021.112073

Ndlovu, T., Mathe, G., & Phiri, L. (2021). Addressing challenges in drug release rates in Sub-Saharan Africa: The case of antiretroviral therapies. African Journal of Pharmacy and Pharmacology, 15(6), 95-102. https://doi.org/10.5897/AJPP2021.5075

Ndlovu, T., Phakathi, S., & Nxumalo, M. (2022). Trends in advanced drug formulation technologies in South Africa. Journal of Southern African Pharmacy, 83(1), 5-11. https://doi.org/10.1016/j.jsap.2022.03.002

Njuguna, A. J., Muiruri, M., & Kamau, M. (2021). Standardizing drug release testing in Kenya: A pathway to improved pharmaceutical quality. East African Medical Journal, 98(4), 1-8. https://doi.org/10.4314/eamj.v98i4.5

Ogunyemi, A. O., Alabi, K. I., & Abioye, A. I. (2020). Evaluation of antibiotic formulations in Nigeria: A study of drug release rates. Journal of Pharmaceutical and Biomedical Analysis, 189, 113487. https://doi.org/10.1016/j.jpba.2020.113487

Okello, S. M., Okwera, A., & Ssenyonga, R. (2019). Evaluation of drug release rates in essential medications in Uganda: A retrospective study. African Journal of Pharmacy and Pharmacology, 13(8), 109-115. https://doi.org/10.5897/AJPP2019.5000

Patel, A. (2021). Nanoscale phenomena: Implications for drug delivery systems. Nanomedicine: Nanotechnology, Biology, and Medicine, 29, 102244. https://doi.org/10.1016/j.nano.2021.102244

Patel, A. (2022). Synthesis of silver nanoparticles for antimicrobial drug delivery. International Journal of Pharmaceutics, 605, 120774. https://doi.org/10.1016/j.ijpharm.2021.120774

Saha, S., Bhattacharya, J., & Ghosh, S. (2020). Gold nanoparticles in drug delivery: A review of their role in drug release rates and cellular interactions. Nanomedicine: Nanotechnology, Biology, and Medicine, 24, 102125. https://doi.org/10.1016/j.nano.2019.102125

Sharma, P. (2021). Polymeric nanoparticles as drug carriers: Enhancing solubility and bioavailability. Journal of Pharmacy and Bioallied Sciences, 13(4), 653-659. https://doi.org/10.4103/jpbs.JPBS_58_21

Sharma, R., & Kumar, P. (2022). Innovations in controlled release drug formulations in India: Market trends and future prospects. Asian Journal of Pharmaceutical Sciences, 17(4), 532-541. https://doi.org/10.1016/j.ajps.2021.09.009

Tanaka, T. (2021). Regulatory landscape for controlled-release formulations in Japan: Trends and implications. Drug Development and Industrial Pharmacy, 47(7), 1107-1115. https://doi.org/10.1080/03639045.2020.1780615

Vishwakarma, K., Yadav, A., & Singh, V. (2021). Silver nanoparticles: A novel approach in drug delivery with enhanced release rates. Materials Science and Engineering: C, 124, 112073. https://doi.org/10.1016/j.msec.2021.112073

Zhang, H. (2023). Microfluidic synthesis of lipid-based nanoparticles for drug delivery. Journal of Drug Delivery Science and Technology, 50, 103138. https://doi.org/10.1016/j.jddst.2022.103138

Zhang, Y., Zhang, Q., & Li, Z. (2022). Polymeric nanoparticles for drug delivery: Tailoring drug release rates through structural modifications. International Journal of Pharmaceutics, 601, 120550. https://doi.org/10.1016/j.ijpharm.2021.120550

Downloads

Published

2024-10-25

How to Cite

Kang C. C. (2024). Synthesis of Nanoparticles for Drug Delivery in Korea. Journal of Chemistry, 3(3), 1–13. https://doi.org/10.47672/jchem.2514

Issue

Section

Articles